[1] |
Amagai M. Pemphigus as a paradigm of autoimmunity and cell adhesion[J]. Keio J Med, 2002,51(3):133⁃139.
|
[2] |
冯素英, 周武庆, 张洁尘, 等. 天疱疮患者桥粒芯糖蛋白抗体水平和疾病活动度关系及变化规律分析[J]. 中华皮肤科杂志, 2014,47(7):461⁃464. doi: 10.3760/cma.j.issn.0412⁃4030. 2014.07.003.
|
[3] |
De D, Khullar G, Handa S, et al. Correlation between salivary and serum anti⁃desmoglein 1 and 3 antibody titres using ELISA and between anti⁃desmoglein levels and disease severity in pemphigus vulgaris[J]. Clin Exp Dermatol, 2017,42(6):648⁃650. doi: 10.1111/ced.13124.
|
[4] |
Murrell DF, Pena S, Joly P, et al. Diagnosis and management of pemphigus: recommendations by an international panel of experts[J]. J Am Acad Dermatol, 2018. doi: 10.1016/j.jaad.2018. 02.021.
|
[5] |
中国医师协会皮肤科医师分会自身免疫疾病亚专业委员会. 寻常型天疱疮诊断和治疗的专家建议[J]. 中华皮肤科杂志,2016,49(11):761⁃765. doi: 10.3760/cma.j.issn.0412⁃4030.2016. 11.01.
|
[6] |
Beutner EH, Jordon RE. Demonstration of skin antibodies in sera of pemphigus vulgaris patients by indirect immunofluorescent staining[J]. Proc Soc Exp Biol Med, 1964,117:505⁃510.
|
[7] |
Anand V, Khandpur S, Sharma VK, et al. Utility of desmoglein ELISA in the clinical correlation and disease monitoring of pemphigus vulgaris[J]. J Eur Acad Dermatol Venereol, 2012,26(11):1377⁃1383. doi: 10.1111/j.1468⁃3083.2011.04294.x.
|
[8] |
Bardazzi F, Balestri R, Ismaili A, et al. Analysis of immunological profile, clinical features and response to treatment in pemphigus[J]. G Ital Dermatol Venereol, 2017,152(6):569⁃577. doi: 10. 23736/S0392⁃0488.16.05307⁃4.
|
[9] |
Daneshpazhooh M, Chams⁃Davatchi C, Khamesipour A, et al. Desmoglein 1 and 3 enzyme⁃linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity[J]. J Eur Acad Dermatol Venereol, 2007,21(10):1319⁃1324. doi: 10.1111/j.1468⁃3083. 2007.02254.x.
|
[10] |
钟珊, 邱于芳, 韩蓓蓓, 等. 应用酶联免疫吸附试验检测血清桥粒芯蛋白抗体水平监测寻常型天疱疮患者病情变化[J]. 北京大学学报: 医学版, 2011,43(3):414⁃420.
|
[11] |
王佩茹, 钟珊, 陈喜雪, 等. 血清抗Dsg1特异性抗体水平变化与落叶型天疱疮病情的关系[J]. 中国皮肤性病学杂志, 2010,24(12):1088⁃1091.
|
[12] |
Takahashi H. Desmoglein 3⁃reactive B cells "hiding" in pemphigus lesions[J]. J Invest Dermatol, 2017,137(11):2255⁃2257. doi: 10.1016/j.jid.2017.07.823.
|
[13] |
Spindler V, Eming R, Schmidt E, et al. Mechanisms causing loss of keratinocyte cohesion in pemphigus[J]. J Invest Dermatol,2018,138(1):32⁃37. doi: 10.1016/j.jid.2017.06.022.
|
[14] |
Sardana K, Garg VK, Agarwal P. Is there an emergent need to modify the desmoglein compensation theory in pemphigus on the basis of Dsg ELISA data and alternative pathogenic mechanisms?[J]. Br J Dermatol, 2013,168(3):669⁃674. doi: 10.1111/bjd.12012.
|
[15] |
李志量, 张洁尘, 徐浩翔, 等. 胆碱能受体激动剂逆转天疱疮棘层松解的机制研究[J]. 中华皮肤科杂志, 2015,48(4):261⁃265. doi: 10.3760/cma.j.issn.0412⁃4030.2015.04.011.
|
[16] |
Ahmed AR, Carrozzo M, Caux F, et al. Monopathogenic vs multipathogenic explanations of pemphigus pathophysiology[J]. Exp Dermatol, 2016,25(11):839⁃846. doi: 10.1111/exd.13106.
|
[17] |
Koga H, Ohyama B, Tsuruta D, et al. Five Japanese cases of antidesmoglein 1 antibody⁃positive and antidesmoglein 3 antibody⁃negative pemphigus with oral lesions[J]. Br J Dermatol, 2012,166(5):976⁃980. doi: 10.1111/j.1365⁃2133.2012.10827.x.
|
[18] |
Walter E, Vielmuth F, Rotkopf L, et al. Different signaling patterns contribute to loss of keratinocyte cohesion dependent on autoantibody profile in pemphigus[J]. Sci Rep, 2017,7(1):3579. doi: 10.1038/s41598⁃017⁃03697⁃7.
|